Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

INTRODUCTION: Gene expression analysis is used to subtype breast cancers such that the most aggressive tumors are identified, but translating this into clinical practice can be cumbersome. Our goal is to develop a universal biomarker that distinguishes patients at high risk across all breast cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Habibi, Golareh, Leung, Samuel, Law, Jennifer H, Gelmon, Karen, Masoudi, Hamid, Turbin, Dmitry, Pollak, Michael, Nielsen, Torsten O, Huntsman, David, Dunn, Sandra E
Formato: Artigo
Idioma:English
Publicado em: BioMed Central 2008
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2614522/
https://ncbi.nlm.nih.gov/pubmed/18925950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2614522/
https://ncbi.nlm.nih.gov/pubmed/18925950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2156

Registos relacionados